PRODUCT DETAIL

Verimmus 5 mg tablety

Code

2339D

MA number

44/0266/19-S

Product Form:

tbl 90x5 mg (blis.OPA/Al/PVC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Mutual recognition procedure

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EG	Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EG02	Everolimus

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	28.08.2019
SPC:	SPC_Verimmus 5 mg tablety_05.2022.pdf
PIL:	PIL_Verimmus 5 mg tablety_05.2022.pdf
Safety feature	Yes
Data update:	17.03.2023